Erlotib 150Mg Tab
₹24396.97*
MRP ₹29752.4
18% off
₹25289.4*
MRP ₹29752.4
15% CB
₹4463 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Erlotib 150Mg Tab belongs to the group of medicine called ‘anti-cancer’ primarily used for lung and pancreatic cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. In this disease, cells of the lung grow uncontrollably, and if not detected at an early stage may spread to other body parts, including the brain. Pancreatic cancer is an uncontrolled cancerous growth in the pancreas, usually in the cells that produce insulin.
Erlotib 150Mg Tab contains 'Erlotinib' that belongs to the group of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it prevents the spread of cancerous cells.
Take Erlotib 150Mg Tab as prescribed by your doctor. You are suggested to take Erlotib 150Mg Tab as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side-effects such as abdominal pain, bone pain, breathlessness, constipation, cough, diarrhea, edema (swelling), fatigue, fever, infection, muscle pain, nausea, rash, stomatitis (inflammation of the mouth), vomiting, weight loss abnormal blood tests for the liver function. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking Erlotib 150Mg Tab for as long as your doctor has prescribed. Do not take Erlotib 150Mg Tab if you are pregnant or planning for pregnancy and breastfeeding as Erlotib 150Mg Tab causes serious congenital disabilities. Older adults are more sensitive to medicine so that they may adjust the dosage according to the condition. While taking Erlotib 150Mg Tab, you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF). Regular blood tests are required to monitor liver function and blood cells in the blood while taking Erlotib 150Mg Tab. Avoid consuming alcohol along with Erlotib 150Mg Tab as it could lead to increased dizziness.
Erlotib 150Mg Tab is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Erlotib 150Mg Tab travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Erlotib 150Mg Tab contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Erlotib 150Mg Tab targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Erlotib 150Mg Tab stops the production, spread, and growth of cancerous cells in the body.
Do not take Erlotib 150Mg Tab if you are allergic to Erlotib 150Mg Tab or any of its ingredients. While taking Erlotib 150Mg Tab, you might become more sensitive to sunlight, so it is important to protect your skin with a high sun protection factor (SPF) while going out as it can lead to a skin rash if you are not using a strong SPF. Erlotib 150Mg Tab can cause leg swelling and water retention or fluid overload (edema), so if you have unexpected rapid weight gain, please consult your doctor. Do not take Erlotib 150Mg Tab if you are pregnant or planning to get pregnant and breastfeeding as it could harm the unborn baby. Use effective birth control measures while taking this medication and for at least 1 month after your last dose. Erlotib 150Mg Tab is not recommended for children and adolescents. You are advised to stop smoking while taking Erlotib 150Mg Tab as smoking could decrease this medication's effect. Erlotib 150Mg Tab may make you more susceptible to infections, consult your doctor if you develop any signs of infections, fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising. Erlotib 150Mg Tab may cause blurry vision and dizziness, so do not drive or operate any machinery which requires concentration. Before undergoing any surgery, it is advised to tell the medical professional who performs the procedure about all the medicines you are taking.
Drug-Drug Interaction: Erlotib 150Mg Tab is known to interact with blood thinners (warfarin, aspirin), anti-hypertensive medicines (amlodipine, metoprolol, nifedipine), heart medicines (quinidine, atorvastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin), immuno-suppressants (cyclosporine), antibiotics (erythromycin, telithromycin, clarithromycin, rifampicin, ciprofloxacin), anti-fungal medicines (itraconazole, voriconazole, ketoconazole), mental illness medicines (triazolam, alprazolam, estazolam, primidone, phenobarbital, phenytoin, phenytoin, carbamazepine), anti-HIV medicines (saquinavir, ritonavir), erectile dysfunction medicine (sildenafil), antiulcer (omeprazole, ranitidine).
Drug-Food Interaction: Erlotib 150Mg Tab is known to interact with alcohol, St. John's wort plant (a natural remedy to treat depression), and grapefruit.
Drug-Disease Interaction: Erlotib 150Mg Tab is known to interact in patients with hypothyroidism (underactive thyroid), cardiovascular disease, bone marrow suppression, liver or kidney disease, fluid retention, gastrointestinal disorders, stomach ulcer or bleeding, high blood pressure, diabetes, and chemotherapy.
Lung cancer: It happens when cells in the lung begin to grow in an uncontrolled manner. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Persons who smoke are at high risk of lung cancer. A common symptom of NSCLC is a cough that does not go quickly followed by shortness of breath. Cancerous cells of the lung spread off and travel through the bloodstream to distant regions of the body and grow.
Pancreatic cancer: It is a type of tumor in the pancreas that usually begins in the juice's cells. It is a gland behind your stomach that produces juices that help break down food and the hormones that help control blood sugar levels.
Country of origin
Manufacturer/Marketer address
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with Erlotib 150Mg Tab as it may increase the risk of side effects such as dizziness, drowsiness, or difficulty in concentrating.
Pregnancy
Unsafe
Erlotib 150Mg Tab is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or at least 6 months after taking the last dose of Erlotib 150Mg Tab.
Breast Feeding
Unsafe
Erlotib 150Mg Tab should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant.
Driving
Caution
It is not known if Erlotib 150Mg Tab affects your driving ability or not. Drive only if you are physically stable and mentally focussed. If you experience drowsiness after taking this medication, you should not drive or operate any machinery or vehicles.
Liver
Caution
Erlotib 150Mg Tab should be taken with caution in patients dealing with liver disease. The doctor may adjust the dose according to the medical condition of the patient.
Kidney
Caution
Erlotib 150Mg Tab is safe to take by patients dealing with kidney disease as prescribed by their doctor. The doctor may adjust the dose according to the medical condition of the patient.
Children
Unsafe
Erlotib 150Mg Tab is not recommended for children below 18 years as the safety and effectiveness were not established.
Product Substitutes